Convergence of Cloud, Data and AI Ignites Innovation at Gilead

The convergence of cloud, data and AI is revolutionizing the pharmaceutical industry, creating a powerful ecosystem that drives innovation, efficiency and precision across the entire value chain. At Gilead, teams harness these technologies on a unified platform, accelerating drug discovery, streamlining clinical trials and enabling smarter manufacturing processes. Our approach leverages Databricks and data mesh to manage vast amounts of heterogeneous data, eliminating silos and enhancing collaboration. This integration facilitates personalized medicine, targeted marketing and optimized supply chains. This session will showcase use cases of traditional AI/ML and Generative AI, demonstrating how this cloud-based, AI-powered platform is transforming drug discovery, development, manufacturing and commercialization. Join us to explore the future of pharmaceutical innovation, where the synergy of cloud, data and AI is unlocking new possibilities for a healthier world.